baber/WOPTO huggingface dataset:
Patent AU-3792385-A (AU)
Title: Method of encoding n-bit information words into m-bit code words, apparatus for carrying out said method, method of decoding m-bit code words into n-bit information words, and apparatus for carrying out said method
Inventor: IMMINK KORNELIS ANTONIE SCHOUH
IPC: H04L25/49
Filed: 1985-01-18
Abstract: A method of encoding n-bit information words into a m-bit code words and the other way round is described, which code words have a specific disparity d and a digital sum value which is limited to values p and q. In order to enable encoding and decoding without the use of an extensive look-up table use is made of a series of numbers which is a modified version of numbers in conformity with the Newton binomial. By means of this modified series the n-bit information words, which are arranged in conformity with their binary weights, are mapped lexicographically and unambiguously onto code words with limited digital sum value, and the other way round.
Patent AU-3846795-A (AU)
Title: Hydraulic speed variator
Inventor: CANOSA REBOREDO ELENA
IPC: F16H39/32
Filed: 1995-11-06
Abstract: It comprises an integral block of a variator assembly which includes a hydropump cylinder (29), a hydromotor cylinder (39), the end-plates (30, 55) and a intermediary plate (38, 43) with ports for the fluid from the hydropump to the hydromotor at high pressure and from the hydromotor to the hydropump at low pressure to close the circuit. The shafts of the rotors (40, 50) of the hydropump and of the hydromotor have a common geometrical axis (22) which is static with respect to the outside and on which they may rotate independently, said rotation motion being the only motion possible. The variator assembly has as unique possible motion the rotation with respect to a geometrical axis (23) which is fixed with respect to the outside and different from the geometrical axis (65) of the cylinder (29) of the hydropump, different also from the geometrical axis (66) of the cylinder of the hydromotor (39) and different from the common geometrical axes (22) of the rotors. A rotation of the variator assembly is caused from the outside and causes the geometrical axes of the cylinder (29) of the hydropump and of the cylinder (39) of the hydromotor to come closer to or move away from the geometrical axes of their respective rotors (40, 50), thereby causing the variation in the ratio between the rotation speeds of the hydropump rotor (40) and the hydromotor rotor (50). <IMAGE>
Patent AU-3865700-A (AU)
Title: Synchronization and cell search method and apparatus for wireless communications
Inventor: OTTOSSON TONY
IPC: H04L7/00
Filed: 2000-03-03
Abstract: A received communications signal is correlated with a common synchronization code to produce a synchronization detection signal. A component of the synchronization detection signal associated with a known synchronization signal is canceled from the synchronization detection signal to produce an interference-canceled synchronization detection signal. Timing of a synchronization signal is determined from the interference-canceled synchronization detection signal. According to one aspect, interference cancellation is achieved by generating a correlation of an estimated received known synchronization signal with the common synchronization code, canceling the correlation of the estimated received known synchronization signal with the common synchronization code from the synchronization detection signal to produce the interference-canceled synchronization detection signal. Timing of a synchronization signal may then be determined by accumulating the interference-canceled synchronization detection signal over a time interval, detecting a peak in the accumulated interference-canceled synchronization detection signal, and determining timing of a synchronization signal from the detected peak. According to another aspect, interference cancellation is achieved by accumulating the synchronization detection signal over a time interval, identifying a peak in the accumulated synchronization detection signal not associated with a known synchronization signal, and determining timing of a synchronization signal from the identified peak. Related terminal apparatus are also discussed.
Patent AU-3917699-A (AU)
Title: Method for coating medical implants
Inventor: LAYROLLE PIERRE JEAN FRANCOIS
IPC: A61F2/30
Filed: 1999-07-12
Abstract: The present invention relates to a method for coating a medical implant, wherein the implant is submersed in an aqueous solution of magnesium, calcium and phosphate ions through which a gaseous weak acid is passed, the solution is degassed, and the coating is allowed to precipitate onto the implant. The invention further relates to a medical implant coated in said method and to a device for use in said method.
Patent AU-4050589-A (AU)
Title: Reagent for use in ld-1 assay
Inventor: SHIHABI ZAK
IPC: C12Q1/32
Filed: 1989-07-25
Abstract: Activity of lactate dehydrogenase isoenzymes LD-2 through LD-5 is selectively inhibited in serum samples by a reagent which operates at neutral to alkaline pH and which comprises the reaction product of a protein denaturing agent and a thiocyanate anion. The level and relative ratio of the remaining LD-1 enzyme are indications of the onset and progress of heart trauma, such as myocardial infarction. The accuracy, speed and precision of the reagent make it suitable for use in automated analyzers as well as in manual methods of analyzing serum samples for LD-1.
Patent AU-4059993-A (AU)
Title: 1-piperazino-1,2-dihydroindene derivatives
Inventor: BOGESO KLAUS
IPC: C07D487/04
Filed: 1993-04-23
Abstract: Trans isomers of 1-piperazino-1,2-dihydroindene compounds having formula (I),    <IMAGE>  I  wherein X and Y are hydrogen, halogen, trifluoromethyl, alkyl, alkylthio, trifluoromethylthio, alkoxy, hydroxy, alkylsulfonyl, amino, alkylamino, nitro or cyano; Ar is a phenyl, thienyl or furyl group, each optionally substituted; R1 is hydrogen, or optionally hydroxy substituted alkyl, alkenyl, cycloalkyl or cycloalkylalkyl; R2 is alkyl, alkenyl, cycloalkyl, or cycloalkylalkyl; or R1 and R2 together form a 5 to 7-membered heterocyclic ring fused with the piperazine ring, which ring may be substituted with hydroxy; R3 is hydrogen, alkyl, alkenyl, cycloalkyl or cycloalkylalkyl; or R2 and R3 together form a 3 to 7-membered carbocyclic ring which is spiro-fused to the piperazine ring; and R4 is hydrogen or alkyl. The compounds of the invention have potent antagonist action on dopamine D1 receptors and are useful in the treatment of diseases of the central nervous system, such as psychoses, schizophrenia (positive as well as negative symptoms), anxiety, depression, sleep disturbances, migraine, Parkinson's disease or cocaine abuse.
Patent AU-4286685-A (AU)
Title: Impeller
Inventor: DESCHAMPS JOHN ALEXANDER
IPC: F04D7/04
Filed: 1985-05-24
Abstract: An impeller for a pump comprises a plurality of interconnected components (20, 23, 32) of an abrasive resistant material such as alumina supported on a resiliently flexible material such as polyurethane.
Patent AU-4328801-A (AU)
Title: Simultaneous stimulation and concentration of cells
Inventor: BERENSON RON
IPC: A61K39/00
Filed: 2001-02-26
Abstract: The present invention relates generally to methods for stimulating cells, and more particularly, to a novel method to concentrate and stimulate cells that maximizes stimulation and/or proliferation of such cells. In the various embodiments, cells are stimulated and concentrated with a surface yielding enhanced proliferation, cell signal transduction, and/or cell surface moiety aggregation. In certain aspects methods for stimulating a population of cells such as T-cells, by simultaneous concentration and cell surface moiety ligation are provided by contacting the population of cells with a surface, that has attached thereto one or more agents that ligate a cell surface moiety and applying a force that predominantly drives cell concentration and cell surface moiety ligation, thereby inducing cell stimulation, cell surface moiety aggregation, and/or receptor signaling enhancement. Also provided are methods for producing phenotypically tailored cells, including T-cells for the use in diagnostics, drug discovery, and the treatment of a variety of indications, including cancer, viral infection, and immune related disorders. Compositions of cells having specific phenotypic properties produced by these processes are further provided.
Patent AU-4337489-A (AU)
Title: Matrix with immunomodulating activity
Inventor: MOREIN BROR
IPC: C07H3/06
Filed: 1989-09-28
Abstract: PCT No. PCT/SE89/00528 Sec. 371 Date May 21, 1991 Sec. 102(e) Date May 21, 1991 PCT Filed Sep. 28, 1989 PCT Pub. No. WO90/03184 PCT Pub. Date Apr. 5, 1990The invention claims an iscom matrix which is not a lipid vesicle comprising at least one lipid and at least one saponim but no intentional antigenic determinants and optionally also adjuvants for use as an immunomodulating agent, medicines, vaccines, kits containing the matrix and new saponins, and a process for preparing the new saponins. The invention also concerns a process for preparing the matrix characterized in that at least one sterol is solubilized in a solvent or detergent, the saponin or saponins are added, the other adjuvants and lipids are optionally also added, whereafter the organic solvent or the detergent may be removed for example with dialysis, ultra filtration, gel filtration or electrophoresis. The sterol and saponin might also be solubilized in the lipids and/or adjuvants.
Patent AU-4414100-A (AU)
Title: Method and device for extracting dna, rna and proteins from biological samples
Inventor: GAZEAU MICHEL
IPC: C12N15/10
Filed: 2000-05-05
Abstract: A device for grinding biological samples to extract DNA, RNA and proteins including a multiplicity of rotary hammers supported by a hammer-carrier block and a lower mobile tray, the tray being movable between an operating position close to the hammer-carrier block and a rest position away from the hammer-carrier block, each of the hammers comprising at least one conduit for distribution of liquid.
Patent AU-4615293-A (AU)
Title: Extrudable vinylidene chloride polymeric film
Inventor: BEKELE SOLOMON
IPC: B32B27/08
Filed: 1993-09-06
Abstract: A vinylidene chloride film with improved processing properties such as good thermal stability, enhanced extrudability and reduced stickiness to metal surfaces is made from a vinylidene chloride polymer or copolymer and up to about 2.0% by weight of a soap of a fatty acid as a processing aid.
Patent AU-4836393-A (AU)
Title: Improved method for detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
Inventor: FODSTAD OYSTEIN
IPC: C12N5/071
Filed: 1993-09-10
Abstract: The invention relates to a method for detecting specific target-cells in a simple and time saving way, using paramagnetic particles, antibodies recognizing the Fc portions of target-cell associating antibodies and target-cell associating antibodies directed to specific antigen determinants in the target-cell membranes. Incubation of the cell suspension with a mild detergent and/or second set of antibodies or antibody fragments, prelabeled or not with fluorescent agents, metallocolloids, radioisotopes, biotincomplexes or certain enzymes allowing visualization, with dramatically increase the specificity of the method. The method can further be used for isolation of the target-cells by magnetic field application and kit for performing the method according to the invention is described.
Patent AU-4855790-A (AU)
Title: Polyglycol lubricants for refrigeration compressors and process for preparing the same
Inventor: MCGRAW PHILIP W
IPC: C10N/
Filed: 1990-01-17
Abstract: A refrigeration fluid compositions for compression refrigeration which have an upper solution critical temperature equal to or greater than 60 DEG C are composed of (A) selected hydrochlorofluorocarbons and hydrofluorocarbons and (B) polyether polyols having viscosities of greater than 80 centistokes (8 x 10<-><5> m<2>/s) at 38 DEG C and having a number average molecular weight of from 400 to 2000 wherein the polyols are the residue of an active hydrogen compound such as glycerine or ethylene diamine.
Patent AU-4918400-A (AU)
Title: Method for conducting crash tests using a carriage and corresponding device
Inventor: STEFFAN HERMANN
IPC: G01M7/08
Filed: 2000-05-09
Abstract: The invention relates to a method for conducting crash tests using a carriage, especially for simulating the collision of a motor vehicle with an obstacle, whereby the deceleration forces of an actual collision are simulated by accelerating a crash-test carriage (9) in accordance with the actual deceleration curve, whereby a force is exerted on the crash-test carriage (9) in the direction of acceleration (II) to avoid calibration tests during the test, said force being greater than the force required for acceleration in accordance with the real deceleration curve. In order to achieve the desired acceleration curve in the crash-test carriage (9) or in a device (7) driving the latter, a brake force is exerted in the direction opposite to the direction of acceleration (II), said force being so great that the resulting force accelerates the carriage (9) in accordance with the desired acceleration curve.
Patent AU-5035090-A (AU)
Title: Antisense oligonucleotides to c-myb proto-oncogene and uses thereof
Inventor: GEWIRTZ ALAN M
IPC: C07K14/82
Filed: 1989-11-03
Abstract: Oligonucleotides are provided having a nucleotide sequence complementary to at least a portion of the mRNA transcript of the human c-myb gene. These "antisense" oligonucleotides are hybridizable to the c-myb mRNA transcript. Such oligonucleotides are useful in treating hematologic neoplasms and in inducing immunosuppression. They are particularly useful as bone marrow purging agents.
Patent AU-5169998-A (AU)
Title: Methods for detecting cell apoptosis
Inventor: SIMAN ROBERT
IPC: G01N33/68
Filed: 1997-11-13
Abstract: Methods for the biochemical and immunohistochemical detection of cell apoptosis are described. The methods utilize the detection and measurement of polypeptide fragments generated during apoptosis. Conditions associated with apoptosis may be detected by the methods of this invention. Methods are also presented for the screening of potential therapeutic compounds which inhibit or stimulate apoptosis. Kits for detection of apoptosis and diagnosis of diseases are also provided.
Patent AU-5459396-A (AU)
Title: Steam generator
Inventor: ZIEGLER GEORG
IPC: F22D1/12
Filed: 1996-05-29
Abstract: The steam generator (1) is inserted into a circuit for the direct, selective catalytic reduction of nitrogen oxide in flue gas (19). The economiser is in two parts between which (2a,2b) is the nitrogen oxide catalytic converter (5). The economiser (2a) positioned in front of the catalytic converter in the flow direction of the gas is divided into at least two sections (10a,10b) through which flow in parallel flue gas and heatable working substances. At least one section (10a) is constantly connected to a drum (13) by a pipe (11a,12). The other sections are sealed off from the water circulation by pipes (11b) which can be blocked by shut-off devices (14).
Patent AU-5483390-A (AU)
Title: Enzymatic removal of a protein amino-terminal sequence
Inventor: BECKER GERALD WAYNE
IPC: C07K1/12
Filed: 1990-05-08
Abstract: This disclosure relates to new compounds and to a process for the controlled conversion of such compounds to produce a Protein that comprises an amino acid sequence which is useful as a precursor to human insulin or to a modified human insulin, the amino terminus portion of which sequence does not define a cathepsin C dipeptide removal stop point. The compounds have the formula Met-Y-Protein in which Y is Tyr or Arg.
Patent AU-5504296-A (AU)
Title: Derivatives of phenoxyethylamine having a high affinity for the 5-HT1A receptor, their preparation procedure, their application as medications and pharmaceutical compounds containing them
Inventor: BIGG DENNIS
IPC: C07C271/28
Filed: 1996-04-05
Abstract: Phenoxyethylamine derivatives of general formula (I) having high affinity for the 5-HT1A receptor, methods for preparing same, pharmaceutical compositions containing said derivatives, and their use, in particular as gastric acid secretion inhibitors or as antiemetics, are disclosed. In general formula (I), Ar is phenyl substituted by one or more substituents; and R is a C1-10 hydrocarbon radical selected from straight or branched alkyl, alkenyl or alkynyl radicals, saturated or unsaturated mono- or polycyclic cycloalkyl, cycloalkylalkyl or alkylcycloalkyl radicals; a pyridyl or isoquinolyl radical, phenyl optionally substituted by one or more substituents, and salts thereof.
Patent AU-5511696-A (AU)
Title: Promoters for gene expression
Inventor: LAGOSKY PETER A
IPC: C12N15/00
Filed: 1996-05-16
Abstract: The present invention provides a novel expression system for the production of protein in bacterial hosts. The system utilizes novel promoters that are highly efficient in initializing transcription and therefore enhance protein yield. The promoters comprise the -35 region of the consensus E. coli promoter, the -10 region of the lppP-5 promoter and a spacer between these two regions derived from either the lpp or lacUV5 promoters.
Patent AU-5547094-A (AU)
Title: Hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
Inventor: VAZQUEZ MICHAEL L
IPC: A61K31/40
Filed: 1993-10-29
Abstract: The present invention (divisional of PCT/US93/10552 = EP 94 900 506.0) is related to N-substituted hydroxyethylamino sulfamic acid derivatives of the formula <CHEM> which are useful as retorviral protease inhibitors and in the preparation of compounds of the above parent application.
Patent AU-5786086-A (AU)
Title: Bearing materials
IPC: C22F1/04
Filed: 1986-05-23
Abstract: Bearing materials and a process for the manufacture thereof are described. The bearing alloys are aluminium-based and comprise the following compositions expressed in weight percent; 8 to 35 tin, 1 to 3 copper, 2 to 10 silicon and remainder aluminium apart from incidental impurities. The alloys are preferably bonded to steel. The composite material is then raised in temperatrue preferably within the range 450 DEG  to 500 DEG  C. for a total time between 10 minutes and 90 seconds and then cooled at a cooling rate of at least 50 DEG C./min. for at least part of the temperature drop to ambient temperature. The composite material may optionally be additionally heat-treated thereafter to further improve the properties.
Patent AU-5797690-A (AU)
Title: Gasket for Leaktight Locked Joints
Inventor: PERCEBOIS ALAIN
IPC: F16L17/04
Filed: 1990-06-28
Abstract: An annular gasket 1 for sealing joints between male and female socket pipes has an anchoring structure 2 and a sealing body 3, the anchoring structure having an anchoring heel 5 provided with outer peripheral recesses 27.
Patent AU-6017800-A (AU)
Title: Novel amide derivatives
Inventor: SAGARA YUFU
IPC: A61P1/04
Filed: 2000-07-14
Abstract: This invention relates to compounds which are represented by the general formula ÄIÜ <CHEM> Äin which A stands for a group of the following formula ÄaoÜ or Äb0Ü   <CHEM> Ar<1>, Ar<2> and Ar<3> stand for optionally substituted phenyl; k stands for 0 or 1; m, n and s stand for 0, 1 or 2; R<1> stands for hydrogen or optionally substituted lower alkyl; R<2>, R<3>, R<4> and R<5> either stand for hydrogen or optionally substituted lower alkyl, or R<2> and R<3>, or R<4> and R<5> together stand for trimethylene and the like; R<60> stands for hydrogen, alkyl, or the like; R<61>and R<71> either stand for alkyl and the like, or together stand for trimethylene and the like; X stands for carbonyl or methylene; Y stands for nitrogen or methine; and Q<-> stands for anionÜ, and the like. The compounds of the invention exhibit selective antagonism to muscarinic M3 receptors, and therefore are useful as safe and effective agents showing little side effect, for treating diseases of the respiratory, urinary and digestive systems.
Patent AU-6143200-A (AU)
Title: Pyrazinones, compositions containing such compounds
Inventor: HAN YONGXIN
IPC: A61K38/00
Filed: 2000-07-17
Abstract: Compounds represented by formula I:as well as pharmaceutically acceptable salts, esters, N-oxides and hydrates thereof are disclosed. Pharmaceutical compositions and methods of use are also included. The compounds are active against the caspase-3 enzyme, and thus are useful to treat caspase-3 mediated diseases and conditions.
Patent AU-6256100-A (AU)
Title: Methods and apparatus for preparation of lipid vesicles
Inventor: KNOPOV VICTOR
IPC: A61K48/00
Filed: 2000-07-14
Abstract: Fully lipid-encapsulated therapeutic agent particles of a charged therapeutic agent are prepared by combining a lipid composition containing preformed lipid vesicles, a charged therapeutic agent, and a destabilizing agent to form a mixture of preformed vesicles and therapeutic agent in a destabilizing solvent. The destabilizing solvent is effective to destabilize the membrane of the preformed lipid vesicles without disrupting the vesicles. The resulting mixture is incubated for a period of time sufficient to allow the encapsulation of the therapeutic agent within the preformed lipid vesicles. The destabilizing agent is then removed to yield fully lipid-encapsulated therapeutic agent particles. The preformed lipid vesicles comprise a charged lipid which has a charge which is opposite to the charge of the charged therapeutic agent and a modified lipid having a steric barrier moiety for control of aggregation.
Patent AU-6328499-A (AU)
Title: Polymers of a hydrophobic nature, filled with starch complexes
Inventor: BASTIOLI CATIA
IPC: C08K5/00
Filed: 1999-09-22
Abstract: Hydrophobic polymers incompatible with starch containing, as a filler, a starch complex dispersed in the polymer matrix in the form of particles with numeric mean dimension of less than 3 microns, bound to the polymer matrix by coupling agents containing groups compatible with the matrix and with the complex, in which the starch complex is characterized by second-derivative IR absorption in the region of 940-952 cm -1  are described or wherein the starch complex is bound to the polymeric matrix through reactive groups contained in the complex capable of being fixed to the polymeric matrix.  The starch complex in the case of biodegradable polymers such as the aliphatic or aliphatic aromatic polyesters is formed with complexing agents different from the polymer forming the matrix and from EVOH copolymers.
Patent AU-6486094-A (AU)
Title: Endoscopic surgical instrument with pivotable and rotatable staple cartridge
Inventor: SMITH JACK E
IPC: A61B17/34
Filed: 1994-06-21
Abstract: A surgical instrument (50) is provided which is insertable through an endoscopic tube to enable a surgeon to perform a surgical technique inside a body cavity. The surgical instrument includes a shaft with a pivotally mounted tip (60) attached thereto, the shaft extending from a handle (80) for gripping the instrument for insertion to the body cavity. The tip (60) of the shaft is adjustable to different angular orientations relative to the support shaft (70) and is rotatable at any angular orientation of the tip. The support shaft (70) may be rotatable about its longitudinal axis relative to the handle (80), or it may be fixed with respect to the handle, in which case the handle may be rotated to rotate the shaft inside the body cavity. The surgical instrument comprises an endoscopic stapling device and the tip of the instrument comprises a staple cartridge (100) which is rotatable 360 DEG  about its axes after the cartridge has been articulated with respect to the support shaft. An improved device for articulating the shaft tip (60) is also provided in which a control knob is mounted to the support shaft for providing sweeping articulation of the shaft tip. Separate actuator mechanisms (82,84) are provided on the handle to control the pivotal movement of the shaft tip, as well as the rotation of the shaft tip and the rotation of the support shaft. <IMAGE>